Haemophilia marks a significant milestone in 2024—three decades since its inception. Since its first issue in October 1994, the
Watch the “Meet the Author Series” on the EAHAD Academy! This episode features Johan Blokzijl. Paula Loughnane interviews him
Explore the E-Learning module on Factor XI Deficiency featuring Prof. Gili Kenet and Dr Saskia Schols. Delve into Factor XI
The European Association for Haemophilia and Allied Disorders (EAHAD) commends the International Society’s on Thrombosis and Haemostasis (ISTH) initiative
The European Association for Haemophilia and Allied Disorders is inviting haemophiliaspecialists to apply for two (2) posts on its
We are very happy to inform you about a great opportunity to help delegates with limited access to funding:
Join the EAHAD Social Media Ambassadors Programme for EAHAD 2025! APPLY NOW The Social Media Ambassador Programme aims to
Pharmacy in preparation for Gene Therapy Gene therapy for haemophilia is classified as a genetically modified organism (GMO) product,
New guidance from the EAHAD, ISTH, EHC, WFH: the management of liver disease in people with congenital bleeding disorders
Ana Torres Ortuño – In memoriam It is with deep sadness that we were informed of the passing of